Extracellular vs Intracellular Delivery of CO: Does It Matter for a Stable, Diffusible Gasotransmitter?
Document Type
Article
Journal/Book Title
Journal of Medicinal Chemistry
Publication Date
10-2-2019
Publisher
American Chemical Society
Award Number
NIH 1R15GM124596-01
Funder
NIH
Volume
62
Issue
21
First Page
9990
Last Page
9995
Abstract
Carbon monoxide (CO) is a gasotransmitter produced in humans. An essential unanswered question in the design of carbon monoxide releasing molecules (CORMs) is whether the delivery molecule should be localized extra- or intracellularly to produce desired biological effects. Herein we show that extracellular CO release is less toxic and is sufficient to produce an anti-inflammatory effect similar to that of intracellular CO release at nanomolar concentrations. This information is valuable for the design of CORMs.
Recommended Citation
Soboleva, Tatiana, et al. “Extracellular vs Intracellular Delivery of CO: Does It Matter for a Stable, Diffusible Gasotransmitter?” Journal of Medicinal Chemistry, vol. 62, no. 21, Nov. 2019, pp. 9990–95. DOI.org (Crossref), doi:10.1021/acs.jmedchem.9b01254.